3FV-54047-74759
3 vaccinations
5 coded responses
32 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 117 / NY
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QQ6-24950-59770
Child or adolescent in my care · Male · 2021-11-14
69E-16976-04260
Child or adolescent in my care · Female · 2021-11-14
Timeline
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Registered in v-safe
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-05
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-13
- 2021-01-18
-
2021-01-25
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
-
2021-03-01
Survey response — day 35, dose 2MedDRA: Dizziness, Upper-airway cough syndrome — Feeling: FairFree text: Dizziness and post nasal drip. However, I had worked 2 16 hour shifts overnight and it is change of season soonMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-04-26
-
2021-10-29
Dose 3 — Pfizer-BioNTech
-
2021-10-29
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-03
- 2021-11-04
- 2021-11-05
-
2021-11-12
Survey response — day 14, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: I've developed cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
-
2021-12-03
Survey response — day 35, dose 3MedDRA: Nasal congestion — Feeling: FairFree text: Mild stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
-
2022-04-30
Survey response — 6 months, dose 3MedDRA: Nasal congestion, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: PoorFree text: Sore throat, nasal congestion, post nasal dripMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Survey response — 12 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnant · Healthcare visit (other): Regular wellness checksMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-11-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-05 | priority 2/3 | |
| 2022-10-29 | Successful 2022-11-01 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — day 35, dose 2
Symptoms: Dizziness and post nasal drip. However, I had worked 2 16 hour shifts overnight and it is change of season soon
Release 10 — day 14, dose 3
Symptoms: I've developed cold symptoms
Release 10 — day 35, dose 3
Symptoms: Mild stuffy nose
Release 11 — 6 months, dose 3
Symptoms: Sore throat, nasal congestion, post nasal drip
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release